Dr. Reddy’s Laboratories Ltd. ADR (NYSE:RDY) does about 2.03M shares in volume on a normal day but saw 1240401 shares change hands in the recent trading day. The company now has a market cap of 12.21B USD. Its current market price is $14.66, marking a decrease of -0.54% compared to the previous close of $14.74. The 52 week high reached by this stock is $16.89 whilst the lowest price level in 52 weeks is $12.26.
The consensus objective for the share price is $14.68, suggesting that the stock has a potential upside of 0.14% over the period.
The current price level is 2.97%, 6.70%, and 0.65% away from its SMA20, SMA50, and SMA200 respectively, with the RDY price moving above the 50-day SMA on current market day. Dr. Reddy’s Laboratories Ltd. ADR (RDY) stock is down -0.61% over the week and 4.71% over the past month. Its price is -7.16% year-to-date and 4.92% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 69.39 for whole year. Expected sales for next quarter are $92.55B, which analysts say will come at $354.72B for the current fiscal year and next year at $350.68B. In addition, estimates put the company’s current quarterly revenue at an average of $88.27B.
To reach the target analysts have set, the stock logically needs to grow 0.14 percent from here.
Outstanding shares total 833.11M with insiders holding 0.00% of the shares and institutional holders owning 13.86% of the company’s common stock. The company has a return on investment of 16.71% and return on equity of 18.36%. The price to earnings ratio (P/E ratio) amounts to 18.30 while the forward price to earnings ratio is 22.72. The beta has a value of 0.33. Price to book ratio is 3.35 and price to sales ratio is 3.17.
